The study by Durnwald et al. conducted in women with metabolic disorders (T2DM, metabolic syndrome) and healthy women who had pregnancies complicated by GDM in the previous 5–10 years showed no differences in FGF21 levels [145]. This evidence concerns the gene FGF21 and type 2 diabetes mellitus.